Supporters and funding
Lung Cancer Europe currently receives funding from these companies. We appreciate their support and hope to continue working together.
Our work is currently supported by:
Amgen
AstraZeneca
Bayer
Blueprint Medicines
BioNTech
Boehringer Ingelheim
Bristol Myers Squib
Daichi-Sankyo
Gilead
Janssen
Lilly
Merck
MSD
Novartis
Regeneron
Pfizer
PharmaMar
Pierre Fabre
Roche
Takeda
ThermoFisher
Funding Source Report
You can access the yearly funding source report for Lung Cancer Europe below: